Position in DARE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,554
-$18,685 QoQ
Shares Held
10,195
-47.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,825,954 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in DARE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,554 | 10,195 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $37,239 | 19,295 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $123,679 | 58,895 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $171,590 | 71,795 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $204,019 | 70,595 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $214,328 | 68,695 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $208,639 | 64,395 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $261,643 | 778,700 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $373,820 | 762,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $222,294 | 719,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $309,909 | 670,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $654,127 | 718,821 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $591,821 | 569,059 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $415,575 | 500,693 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $649,999 | 650,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $450,917 | 366,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $149,505 | 100,339 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $541,130 | 324,030 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $137,195 | 72,590 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,474,369 | 872,408 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $948,311 | 707,695 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $702,896 | 703,600 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $644,911 | 652,084 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $170,864 | 201,017 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||